DR. AGARWAL'S EYE HOSP L (DRAGARWQ) financials

DR. AGARWAL'S EYE HOSP L (DRAGARWQ) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Dr Agarwal's Eye Hospital Ltd is a leading chain of eye hospitals with predominant presence in Tamil Nadu.[1]

Market Cap: ₹2,454Cr.
Current Price: ₹5,077
Stock P/E: 32.2
ROE: 24.2%
ROCE: 17.2%
Book Value: ₹717
Dividend Yield: 0.14%
52W High / Low: ₹6,392/4,412

In Jun 2026, DR. AGARWAL'S EYE HOSP L (DRAGARWQ) reported sales ₹143 Cr and net profit ₹23 Cr.

Annual TTM: sales ₹497 Cr, net profit ₹76 Cr.

Shareholding: Promoters 72.67% (Sep 2026), FIIs 2.22% (Sep 2026), DIIs 2.54% (Sep 2026), Public 22.56% (Sep 2026), No. of Shareholders 21,392% (Sep 2026).

DRAGARWQ quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	102	95	100	117	118	116	120	143
Expenses	72	69	68	80	78	82	86	100
Operating Profit	30	26	32	37	40	34	34	43
OPM %	29%	27%	32%	32%	34%	30%	28%	30%
Other Income	2	2	0	1	1	3	2	2
Interest	4	4	3	4	4	2	2	3
Depreciation	9	10	10	11	11	12	12	11
Profit before tax	19	14	19	23	26	23	21	31
Tax %	26%	26%	14%	26%	25%	26%	24%	24%
Net Profit	14	10	16	17	19	17	16	23
EPS in Rs	30.11	22.13	34.02	36.72	39.98	35.76	33.60	48.38
Raw PDF	—	—	—	—	—	—	—	—

DRAGARWQ profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	176	140	201	268	319	397	471	497
Expenses	129	109	143	192	227	277	324	345
Operating Profit	47	31	59	76	92	120	147	151
OPM %	27%	22%	29%	28%	29%	30%	31%	30%
Other Income	3	1	1	2	5	5	6	7
Interest	9	7	7	8	8	15	14	10
Depreciation	21	19	20	20	27	39	46	47
Profit before tax	20	6	32	49	62	71	94	101
Tax %	31%	125%	25%	25%	26%	23%	25%	—
Net Profit	14	-1	24	37	46	55	70	76
EPS in Rs	29.11	-3.06	51.28	78.55	98.64	116.28	145.05	157.72
Dividend Payout %	0%	0%	6%	4%	3%	5%	5%	—

DRAGARWQ balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	5	5	5	5	5	5	5	5
Reserves	41	51	50	73	109	152	205	341
Borrowings	24	60	68	193	232	268	333	326
Other Liabilities	31	24	33	42	44	71	71	94
Total Liabilities	100	141	155	314	390	496	613	766
Fixed Assets	55	94	96	214	260	316	393	403
CWIP	0	0	0	26	62	97	128	197
Investments	0	0	0	0	0	0	13	89
Other Assets	45	47	60	73	67	83	80	78
Total Assets	100	141	155	314	390	496	613	766

DRAGARWQ cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	25	39	34	57	70	90	94	145
Cash from Investing Activity	-25	-17	-11	-46	-71	-70	-133	-174
Cash from Financing Activity	2	-20	-8	-4	0	-14	17	25
Net Cash Flow	2	2	15	7	-1	6	-23	-4
Free Cash Flow	0	22	23	10	-1	19	-9	47
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	111%	96%	120%	112%	107%	112%	95%	105%

DRAGARWQ shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	71.90%	71.90%	71.90%	72.67%	72.67%	72.67%	72.67%	72.67%
FIIs	0.84%	1.33%	1.49%	1.74%	1.82%	2.20%	2.24%	2.22%
DIIs	1.04%	1.95%	2.31%	2.36%	2.36%	2.12%	2.05%	2.54%
Public	26.22%	24.82%	24.29%	23.22%	23.15%	22.99%	23.03%	22.56%
No. of Shareholders	15,115	41,704	35,976	30,528	25,449	24,036	22,954	21,392

DRAGARWQ key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	19	14	23	16	14	15	13	14
Inventory Days	124	132	117	91	73	106	55	51
Days Payable	292	224	401	410	327	345	101	97
Cash Conversion Cycle	-149	-78	-260	-303	-240	-224	-34	-31
Working Capital Days	-22	-34	-70	-58	-50	-63	-51	-55
ROCE %	34%	30%	11%	20%	19%	18%	18%	17%

DRAGARWQUpdated 18 Oct 2026, 20:31

Dr. Agarwal's Eye Hosp L

DRAGARWQUpdated 18 Oct 2026, 20:31

Market Cap

₹2,454Cr.

Current Price

₹5,077

High / Low

₹6,392/4,412

Stock P/E

32.2

ROE24.2%

ROCE17.2%

Book Value₹717

Face Value₹10.0

Dividend Yield0.14%

About

Dr Agarwal's Eye Hospital Ltd is a leading chain of eye hospitals with predominant presence in Tamil Nadu.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	79	2	56	0	6	16	26	12	24.55
Sep 2023	84	2	61	1	6	17	24	13	26.79
Dec 2023	76	2	55	1	7	13	26	9	20.09
Mar 2024	81	2	56	2	8	17	26	13	27.21
Jun 2024	100	3	69	0	10	19	25	14	30.02
Sep 2024	102	4	72	2	9	19	26	14	30.11
Dec 2024	95	4	69	2	10	14	26	10	22.13
Mar 2025	100	3	68	0	10	19	14	16	34.02
Jun 2025	117	4	80	1	11	23	26	17	36.72
Sep 2025	118	4	78	1	11	26	25	19	39.98
Dec 2025	116	2	82	3	12	23	26	17	35.76
Mar 2026	120	2	86	2	12	21	24	16	33.6
Jun 2026	143	3	100	2	11	31	24	23	48.38

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	118	4	103	0	6	5	-6	6	12.13
Mar 2016	137	5	119	-5	9	0	-104	0	0.09
Mar 2017	149	4	126	1	9	11	33	7	15.62
Mar 2018	153	3	129	2	10	13	49	7	14.43
Mar 2019	170	4	140	2	11	17	32	12	25.36
Mar 2020	176	9	129	3	21	20	31	14	29.11
Mar 2021	140	7	109	1	19	6	125	-1	-3.06
Mar 2022	201	7	143	1	20	32	25	24	51.28
Mar 2023	268	8	192	2	20	49	25	37	78.55
Mar 2024	319	8	227	5	27	62	26	46	98.64
Mar 2025	397	15	277	5	39	71	23	55	116.28
Mar 2026	471	14	324	6	46	94	25	70	145.05
TTM	497	10	345	7	47	101	—	76	157.72

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	72.67%
FIIs	2.22%
DIIs	2.54%
Public	22.56%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	71.89%	0.63%	0%	27.47%
Mar 2024	71.89%	0.64%	0%	27.47%
Jun 2024	71.9%	0.65%	0%	27.46%
Sep 2024	71.9%	0.83%	0.96%	26.32%
Dec 2024	71.9%	0.84%	1.04%	26.22%
Mar 2025	71.9%	1.33%	1.95%	24.82%
Jun 2025	71.9%	1.49%	2.31%	24.29%
Sep 2025	72.67%	1.74%	2.36%	23.22%
Dec 2025	72.67%	1.82%	2.36%	23.15%
Mar 2026	72.67%	2.2%	2.12%	22.99%
Jun 2026	72.67%	2.24%	2.05%	23.03%
Sep 2026	72.67%	2.22%	2.54%	22.56%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	5	19	27	18	69	26	0	0	43	69
Mar 2016	5	19	31	24	79	34	1	0	44	79
Mar 2017	5	25	23	20	72	33	1	0	38	72
Mar 2018	5	30	18	28	81	36	3	0	42	81
Mar 2019	5	41	24	31	100	55	0	0	45	100
Mar 2020	5	51	60	24	141	94	0	0	47	141
Mar 2021	5	50	68	33	155	96	0	0	60	155
Mar 2022	5	73	193	42	314	214	26	0	73	314
Mar 2023	5	109	232	44	390	260	62	0	67	390
Mar 2024	5	152	268	71	496	316	97	0	83	496
Mar 2025	5	205	333	71	613	393	128	13	80	613
Mar 2026	5	341	326	94	766	403	197	89	78	766

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	14	-10	-5	-1
Mar 2016	17	-17	0	0
Mar 2017	20	-8	-12	0
Mar 2018	19	-11	-8	0
Mar 2019	25	-25	2	2
Mar 2020	39	-17	-20	2
Mar 2021	34	-11	-8	15
Mar 2022	57	-46	-4	7
Mar 2023	70	-71	0	-1
Mar 2024	90	-70	-14	6
Mar 2025	94	-133	17	-23
Mar 2026	145	-174	25	-4

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	19	24	16	17	19	14	23	16	14	15	13	14
Inventory Days	238	200	123	148	124	132	117	91	73	106	55	51
Days Payable	360	371	277	353	292	224	401	410	327	345	101	97
Cash Conversion Cycle	-103	-146	-138	-189	-149	-78	-260	-303	-240	-224	-34	-31
Working Capital Days	-31	-39	-25	-39	-22	-34	-70	-58	-50	-63	-51	-55
ROCE %	19%	18%	29%	32%	34%	30%	11%	20%	19%	18%	18%	17%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of DR. AGARWAL'S EYE HOSP L (DRAGARWQ)?

The reported market capitalisation for DR. AGARWAL'S EYE HOSP L (DRAGARWQ) is ₹2,454Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of DRAGARWQ?

The current price shown for DR. AGARWAL'S EYE HOSP L (DRAGARWQ) on Fincrux is ₹5,077 with a 52-week high/low of ₹6,392/4,412.

What is the P/E ratio of DR. AGARWAL'S EYE HOSP L (DRAGARWQ)?

The stock P/E for DR. AGARWAL'S EYE HOSP L (DRAGARWQ) is 32.2 on Fincrux, with ROE at 24.2% and ROCE at 17.2%.

What were DRAGARWQ latest quarterly results?

For Jun 2026, DR. AGARWAL'S EYE HOSP L (DRAGARWQ) reported sales ₹143 Cr and net profit ₹23 Cr (figures in ₹ crore unless noted).

What are DRAGARWQ annual sales and net profit?

For TTM, DR. AGARWAL'S EYE HOSP L (DRAGARWQ) shows sales of ₹497 Cr and net profit of ₹76 Cr on the Fincrux profit & loss statement.

Who owns DR. AGARWAL'S EYE HOSP L (DRAGARWQ)?

Latest shareholding for DR. AGARWAL'S EYE HOSP L (DRAGARWQ) on Fincrux: Promoters 72.67% (Sep 2026), FIIs 2.22% (Sep 2026), DIIs 2.54% (Sep 2026), Public 22.56% (Sep 2026), No. of Shareholders 21,392% (Sep 2026).

Where can I find DR. AGARWAL'S EYE HOSP L (DRAGARWQ) financials?

DR. AGARWAL'S EYE HOSP L (DRAGARWQ) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show DRAGARWQ balance sheet and cash flow?

Yes. The DR. AGARWAL'S EYE HOSP L (DRAGARWQ) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 20:31